Journal of Cancer Research and Therapeutics Close
 

Figure 4: Cells were treated with 125I, GEM or concurrent 125I and GEM. At a dose of 4 Gy, Western blot was used to analyse caspase-3 expression and the Bax/Bcl2 ratio in different treatment groups (a). The level of Caspase-3 was significant higher in the group of GEM+125I (b) and Bax/BCL-2 ratio was lower in the group of GEM+125I (c). All experiments were performed in triplicate, and the data are presented as the mean±SD. The T test was used for data analysis. *P < 0.05, **P < 0.01

Figure 4: Cells were treated with <sup>125</sup>I, GEM or concurrent <sup>125</sup>I and GEM. At a dose of 4 Gy, Western blot was used to analyse caspase-3 expression and the Bax/Bcl2 ratio in different treatment groups (a). The level of Caspase-3 was significant higher in the group of GEM+<sup>125</sup>I (b) and Bax/BCL-2 ratio was lower in the group of GEM+<sup>125</sup>I (c). All experiments were performed in triplicate, and the data are presented as the mean±SD. The T test was used for data analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01